Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...
Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB ...
Analysts at Roth Capital issued their Q1 2026 earnings per share estimates for shares of Aurora Cannabis in a research report issued on Thursday, February 6th. Roth Capital analyst W. Kirk expects ...
Aurora Cannabis has a 1 year low of $2.84 and a 1 year high of ... TD Cowen initiated coverage on Aurora Cannabis in a report on Wednesday, December 11th. They issued a “buy” rating for ...
Miguel Martin, the CEO of Aurora Cannabis, said he had no immediate plans to follow his competitors into the US. He added that he's taken heat from investors for not figuring out a way into the US.
Aurora Cannabis CEO Miguel Martin thinks the cannabis industry and its investors are too focused on US recreational consumers and are missing a more profitable opportunity: medical marijuana.
Aurora Cannabis , which belongs to the Zacks Medical - Products industry, posted revenues of $63.04 million for the quarter ended December 2024 ... of today's Zacks #1 Rank (Strong Buy) stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results